Synthomer (LON:SYNT) Shares Pass Below 200-Day Moving Average – Should You Sell?

Synthomer plc (LON:SYNTGet Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 200.83 ($2.47) and traded as low as GBX 130 ($1.60). Synthomer shares last traded at GBX 131 ($1.61), with a volume of 365,391 shares trading hands.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on SYNT. Canaccord Genuity Group decreased their target price on shares of Synthomer from GBX 300 ($3.69) to GBX 275 ($3.39) and set a “buy” rating for the company in a research note on Friday, October 4th. Berenberg Bank decreased their price target on Synthomer from GBX 265 ($3.26) to GBX 230 ($2.83) and set a “buy” rating for the company in a report on Monday, January 6th.

Get Our Latest Stock Report on SYNT

Synthomer Price Performance

The company has a debt-to-equity ratio of 77.42, a quick ratio of 0.97 and a current ratio of 1.90. The company has a 50-day moving average of GBX 158.84 and a 200-day moving average of GBX 200.83. The stock has a market capitalization of £214.28 million, a price-to-earnings ratio of -214.75, a P/E/G ratio of -0.17 and a beta of 1.79.

About Synthomer

(Get Free Report)

Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.

Featured Stories

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.